Market Cap 1.62B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 4,228,400
Avg Vol 7,203,780
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 1%
Beta 1.14
Analysts Strong Sell
Price Target $10.50

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
tradersunion353
tradersunion353 Jul. 28 at 12:49 AM
$ABCL question is how long company will hide about leaked bad phase 2 data…,
0 · Reply
tradersunion353
tradersunion353 Jul. 28 at 12:48 AM
$ABCL over hyped underperforming junk
0 · Reply
bonecrack_benny
bonecrack_benny Jul. 27 at 9:05 PM
$ABCL ❤️
0 · Reply
Samb2344
Samb2344 Jul. 27 at 8:21 PM
$ABCL ughh
0 · Reply
tradersunion353
tradersunion353 Jul. 27 at 8:03 PM
$ABCL disgusting pumpers
0 · Reply
tradersunion353
tradersunion353 Jul. 27 at 8:02 PM
$ABCL leaked bad phase 2 data - abcl 635 is really impacting the stock price not sure what this clowns are celebrating with adding loading comments
0 · Reply
Ckkung71
Ckkung71 Jul. 27 at 8:01 PM
$ABCL wow… one more day on no news…
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 27 at 7:27 PM
$ABCL Carl Hansen left a physics professorship to build $ABCL and still runs it more than a decade later. Technically deep founder, no quarterly theatre. In platform biotech the person choosing what to build matters more than the first molecule.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 27 at 6:30 PM
$ABCL The June Jazz deal got read as $ABCL selling a drug. It did not. Jazz paid for access to the library of CD3 and costimulatory binders. You rent a catalog when the catalog is hard to rebuild. Platform proof, not a product sale.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 27 at 6:28 PM
$ABCL $ABCL earns milestones and royalties on partner molecules it never funded through trials. Over 100 partner programs since 2014, around a dozen already in patients. Shots on goal that someone else paid for.
0 · Reply
Latest News on ABCL
AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 20 days ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 21 days ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 21 days ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 7 weeks ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 2 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 2 months ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 3 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 5 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 5 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 6 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 9 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 9 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 11 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


tradersunion353
tradersunion353 Jul. 28 at 12:49 AM
$ABCL question is how long company will hide about leaked bad phase 2 data…,
0 · Reply
tradersunion353
tradersunion353 Jul. 28 at 12:48 AM
$ABCL over hyped underperforming junk
0 · Reply
bonecrack_benny
bonecrack_benny Jul. 27 at 9:05 PM
$ABCL ❤️
0 · Reply
Samb2344
Samb2344 Jul. 27 at 8:21 PM
$ABCL ughh
0 · Reply
tradersunion353
tradersunion353 Jul. 27 at 8:03 PM
$ABCL disgusting pumpers
0 · Reply
tradersunion353
tradersunion353 Jul. 27 at 8:02 PM
$ABCL leaked bad phase 2 data - abcl 635 is really impacting the stock price not sure what this clowns are celebrating with adding loading comments
0 · Reply
Ckkung71
Ckkung71 Jul. 27 at 8:01 PM
$ABCL wow… one more day on no news…
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 27 at 7:27 PM
$ABCL Carl Hansen left a physics professorship to build $ABCL and still runs it more than a decade later. Technically deep founder, no quarterly theatre. In platform biotech the person choosing what to build matters more than the first molecule.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 27 at 6:30 PM
$ABCL The June Jazz deal got read as $ABCL selling a drug. It did not. Jazz paid for access to the library of CD3 and costimulatory binders. You rent a catalog when the catalog is hard to rebuild. Platform proof, not a product sale.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 27 at 6:28 PM
$ABCL $ABCL earns milestones and royalties on partner molecules it never funded through trials. Over 100 partner programs since 2014, around a dozen already in patients. Shots on goal that someone else paid for.
0 · Reply
Austinhilton
Austinhilton Jul. 27 at 4:14 PM
$SNDK over 11% after Morgan Stanley warns the memory boom is “approaching an inflection point” with contract chip prices expected to peak in late 2026. But a pricing peak doesn't necessarily mean an earnings peak because SanDisk has $42B in RPO from multiyear agreements with price floors near $0.29 per GB allowing contracted volume and rising AI storage demand to keep earnings growing even if NAND prices flatten. $ABCL $LEU
0 · Reply
tradersunion353
tradersunion353 Jul. 27 at 1:56 PM
$ABCL pos dropped 40% on leaked bad phase 2 abcl 635 data and clowns here are celebrating .. 🤮🤮🤮🤮
1 · Reply
tradersunion353
tradersunion353 Jul. 27 at 11:08 AM
$ABCL another 10% drop just for fun,? why not?? pos company
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 27 at 3:07 AM
$ABCL I don't give a FUCK if you have $1000, $10,000 or even $100,000 in your portfolio, Biotech stocks are going to make people generational WEALTH this year.
0 · Reply
snowPOW
snowPOW Jul. 27 at 2:14 AM
$ABCL hey @DeMampCamp That poster was beyond the pale. @Stocktwits Not ok on this board or any other. Blocked and reported. Good to have positive conversation about ABCL and know that as a fellow poster of this board, I won't tolerate that BS. Cheers
1 · Reply
snowPOW
snowPOW Jul. 27 at 2:09 AM
$ABCL https://www.wsj.com/health/pharma/regeneron-george-yancopoulos-drug-discovery-17fea3fa Probably noteworthy, please let me know if it's not.
0 · Reply
Austinhilton
Austinhilton Jul. 26 at 3:05 PM
Buying fundamentally undervalued positions while having your average around their 200 WMA will always protect you Your strategy is time then Anyone that has an issue holding should not be investing. $MRK $CABA $ABCL $LEU
0 · Reply
tradersunion353
tradersunion353 Jul. 26 at 1:10 PM
$ABCL there is some paid group or big bag holders on x and here . whenever stock drops - they flood the platforms with posts that yhry are adding this is a gift . clowns have been misleading investors for last 5 years .. stay away from this pumpers
1 · Reply
tradersunion353
tradersunion353 Jul. 26 at 12:56 PM
$ABCL abcl 635 phase 2 leaked data was bad and stock crashed almost 50% in 2 weeks pos management didnt even do a pr for investors.. what kind of trash biotech is this
0 · Reply
tradersunion353
tradersunion353 Jul. 26 at 12:51 PM
$ABCL still dont get it junk drops from 8.40s to 5 dollars in 2 weeks what are this clowns celebrating for?? no real long term investor would celebrate clowns 🤡🤡🤡🤡
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 25 at 6:45 PM
$ABCL $ABCL is two businesses stapled together: a partner platform earning milestones on molecules it never funded, and an owned pipeline led by ABCL635 that could re rate the whole thing. The market prices the first and ignores the second.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 25 at 6:44 PM
$ABCL $ABCL + Jazz T-cell collab. ABCL635 data already positive. Most still see a tool company. August 5 coming.
0 · Reply